These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37348788)

  • 1. Evaluation and comparison of risk-based and universal prenatal HCV screening programs in Alberta, Canada.
    Thompson LA; Plitt SS; Doucette K; Coffin CS; Klein KB; Robinson JL; Charlton CL
    J Hepatol; 2023 Nov; 79(5):1121-1128. PubMed ID: 37348788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of syphilis coinfection in hepatitis C virus positive prenatal patients from Alberta during a pilot routine screening program.
    Thompson LA; Plitt SS; Gratrix J; Charlton CL
    Can Liver J; 2023 Feb; 6(1):70-75. PubMed ID: 36908571
    [No Abstract]   [Full Text] [Related]  

  • 4. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi-ethnic population: Universal screening is more comprehensive.
    Carey I; Christiana M; Marie-Ange M; Teresa B; Maria GV; Dusheiko G; Agarwal K
    J Viral Hepat; 2022 Dec; 29(12):1079-1088. PubMed ID: 36138559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada.
    Samson L; King S
    CMAJ; 1998 Jun; 158(11):1449-57. PubMed ID: 9629106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of a Canadian provincial prenatal HIV screening program: 2010 to 2014.
    Plitt SS; Smith TR; Berry W; Osman M; Senthilselvan A; Charlton CL
    Can J Public Health; 2020 Aug; 111(4):555-561. PubMed ID: 32016920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy-based screening program to detect hepatitis C in 'baby-boomer' cohorts in western Canada.
    Chiew BA; Fong AY; Cosgrove LT; Mohajerani SA; Ramji A; Lee SS
    Can Liver J; 2023 Dec; 6(4):388-394. PubMed ID: 38152322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respect women, promote health and reduce stigma: ethical arguments for universal hepatitis C screening in pregnancy.
    Gross MS; Ruth AR; Rasmussen SA
    J Med Ethics; 2020 Oct; 46(10):674-677. PubMed ID: 32054774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection and treatment of sexually transmitted disease in pregnant adolescents of low socioeconomic status.
    Matson SC; Pomeranz AJ; Kamps KA
    Clin Pediatr (Phila); 1993 Oct; 32(10):609-12. PubMed ID: 8261726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care.
    Bushman ET; Subramani L; Sanjanwala A; Dionne-Odom J; Franco R; Owen J; Subramaniam A
    Am J Perinatol; 2021 Sep; 38(11):1109-1116. PubMed ID: 33934324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods.
    Blasig A; Wagner EC; Pi D; Bigham M; Remple VP; Craib KJ; Doyle P; Dobson S; Yoshida EM; Patrick D; Krajden M; Money DM;
    Can J Public Health; 2011; 102(2):98-102. PubMed ID: 21608379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasmosis in pregnancy: prevention, screening, and treatment.
    Paquet C; Yudin MH;
    J Obstet Gynaecol Can; 2013 Jan; 35(1):78-81. PubMed ID: 23343802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario.
    Biondi MJ; Lynch K; Floriancic N; Cronin K; Marchand-Austin A; Mendlowitz AB; Capraru C; Kozak RA; Goneau L; Tran V; Mazzulli T; Yudin MH; Hansen B; Eastabrook G; Feld JJ
    J Obstet Gynaecol Can; 2024 Jun; 46(6):102423. PubMed ID: 38452927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective study.
    McCormick CA; Domegan L; Carty PG; Drew R; McAuliffe FM; O'Donohoe O; White N; Garvey P; O'Grady M; De Gascun CF; McCormick PA
    BJOG; 2022 Jan; 129(2):322-327. PubMed ID: 34706147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.